drugset / Trial / NCT02149277

Gcsf Injection in Women With Repeated Implantaiton Failure

NCT02149277 ↗

Phase 3 Terminated 15 enrolled Clinique Ovo
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to see the impact of intrauterine injection of recombinant GCSF on pregnancy and implantation rate during IVF-ICSI (intracytoplasmic sperm injection) protocols as well as in frozen embryo transfer. In addition, following the injection, the level of G-CSF in the bloodstream will be verified.

Timeline

Start
2013-03
Primary completion
2017-12
Completion
2017-12

Outcome

Outcome not reported

Stopped (Enrollment): “Recruitment difficulty”

Drugs

EvaluationDrugModalityDoseRoute
Comparator filgrastim Protein / enzyme biologic 300 ug Other

Indications